Top Markets
Coin of the day
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
Clasificación en acciones #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
Precio por acción
$0.66936954
Última sincronización: 2026-07-28
Capitalización bursátil
$89.04M
Cambio (1 día)
0.00%
Cambio (1 año)
-40.10%
País
TW
Comercio BRIM Biotechnology, Inc. (6885)

Categoría

Ratio P/B de BRIM Biotechnology, Inc. (6885)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de BRIM Biotechnology, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de BRIM Biotechnology, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH